UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Information fusion, ISSN 1566-2535, 10/2020, Volume 62, pp. 89 - 109
Journal Article
Renewable & sustainable energy reviews, ISSN 1364-0321, 02/2018, Volume 82, pp. 2254 - 2269
Solar irradiance | Solar forecasting | Energy harvesting | Machine learning | Science & Technology - Other Topics | Green & Sustainable Science & Technology | Technology | Energy & Fuels | Science & Technology | Wireless sensor networks | Usage | Alternative energy sources | Harvesting | Analysis | Radiation | Batteries | Sensors | Electric power production
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. e452 - e466
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - complications | Venous Thromboembolism - prevention & control | Administration, Oral | Humans | Anticoagulants - therapeutic use | Catheterization, Central Venous - adverse effects | Venous Thromboembolism - drug therapy | Practice Guidelines as Topic | Practice guidelines (Medicine) | Cancer patients | Anticoagulants (Medicine) | Drug therapy | Thromboembolism | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 13, pp. 1211 - 1222
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Venous Thromboembolism - mortality | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Secondary Prevention | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Venous Thromboembolism - prevention & control | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Intention to Treat Analysis | Adult | Female | Aged | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Care and treatment | Aspirin | Venous thrombosis | Dosage and administration | Diagnosis | Fees & charges | Anticoagulants | Stroke | Heart attacks | Embolisms | Committees | Joint surgery | Thrombosis | Patients | Bleeding | Risk factors | Studies | Prevention | Motivation | Thromboembolism | Health risk assessment | Pharmaceuticals | Veins & arteries | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Orthopedic surgery | Prevention and actions | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article